-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Solventum, Raises Price Target to $95

Benzinga·08/06/2026 09:49:15
Listen to the news
BTIG analyst Ryan Zimmerman maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $91 to $95.